Soken-Nakazawa J. Song

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.

K. Yoshizaki, N. Tomosugi, T. Ishikawa, 2010, Blood.

Prediction and experimental validation of a putative non-consensus binding site for transcription factor STAT3 in serum amyloid A gene promoter.

Lokesh P. Tripathi, K. Mizuguchi, Shandar Ahmad, 2013, Biochimica et biophysica acta.

Interleukin-6-producing dermoid cyst associated with multicentric Castleman’s disease

K. Yoshizaki, H. Mizuta, K. Hasegawa, 2012, International Journal of Hematology.

Mechanism and Clinical Significance of IL-6 Combined with TNF-ñ orIL-1 for the Induction of Acute Phase Proteins SAA and CRP in ChronicInflammatory Diseases

K. Yoshizaki, Soken-Nakazawa J. Song, Soken-Nakazawa J. Song, 2016 .